{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:08:44Z","timestamp":1789668524735,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-20257-4","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T22:20:59Z","timestamp":1784499659000},"page":"9134-9140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preoperative Radiologic Assessment of the Axilla in Locally Advanced Breast Cancer After Neoadjuvant Systemic Therapy: A Contemporary Comparison"],"prefix":"10.1245","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4248-3082","authenticated-orcid":false,"given":"Andrew","family":"Seto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Port","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Bernik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6236-6089","authenticated-orcid":false,"given":"Tara","family":"Balija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"20257_CR1","unstructured":"Network NCC. NCCN clinical practice guidelines in oncology (NCCN guidelines) breast cancer version 5.2025. 2025."},{"issue":"10","key":"20257_CR2","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1245\/s10434-013-3118-z","volume":"20","author":"TJ Hieken","year":"2013","unstructured":"Hieken TJ, Boughey JC, Jones KN, et al. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer. Ann Surg Oncol. 2013;20(10):3199\u2013204.","journal-title":"Ann Surg Oncol."},{"issue":"1052","key":"20257_CR3","doi-asserted-by":"publisher","first-page":"20150143","DOI":"10.1259\/bjr.20150143","volume":"88","author":"S You","year":"2015","unstructured":"You S, Kang DK, Jung YS, et al. Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and 18F-FDG PET\/CT. Br J Radiol. 2015;88(1052):20150143.","journal-title":"Br J Radiol."},{"issue":"13","key":"20257_CR4","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1245\/s10434-019-07809-7","volume":"26","author":"D Morency","year":"2019","unstructured":"Morency D, Dumitra S, Parvez E, et al. Axillary lymph node ultrasound following neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: results from the SN FNAC study. Ann Surg Oncol. 2019;26(13):4337\u201345.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"20257_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2214\/AJR.17.18295","volume":"210","author":"HT Le-Petross","year":"2018","unstructured":"Le-Petross HT, Mccall LM, Hunt KK, et al. Axillary ultrasound identifies residual nodal disease after chemotherapy: results from the American College Of Surgeons Oncology Group Z1071 trial (Alliance). AJR Am J Roentgenol. 2018;210(3):669\u201376.","journal-title":"AJR Am J Roentgenol."},{"issue":"4","key":"20257_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","volume":"3","author":"M Pilewskie","year":"2017","unstructured":"Pilewskie M, Morrow M. Axillary nodal management following neoadjuvant chemotherapy: a review. JAMA Oncol. 2017;3(4):549\u201355.","journal-title":"JAMA Oncol."},{"issue":"10","key":"20257_CR7","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072\u20138.","journal-title":"J Clin Oncol."},{"issue":"2","key":"20257_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/tbj.13488","volume":"26","author":"K Shin","year":"2020","unstructured":"Shin K, Weaver O, Wei W, et al. Sonographic features of benign and malignant axillary nodes post-neoadjuvant chemotherapy. Breast J. 2020;26(2):182\u20137.","journal-title":"Breast J."},{"issue":"30","key":"20257_CR9","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","volume":"33","author":"JC Boughey","year":"2015","unstructured":"Boughey JC, Ballman KV, Hunt KK, et al. Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American College of Surgeons Oncology Group Z1071 trial (Alliance). J Clin Oncol. 2015;33(30):3386\u201393.","journal-title":"J Clin Oncol."},{"issue":"6","key":"20257_CR10","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jamcollsurg.2017.08.027","volume":"225","author":"JJ Weber","year":"2017","unstructured":"Weber JJ, Jochelson MS, Eaton A, et al. MRI and prediction of pathologic complete response in the breast and axilla after neoadjuvant chemotherapy for breast cancer. J Am Coll Surg. 2017;225(6):740\u20136.","journal-title":"J Am Coll Surg."},{"issue":"13","key":"20257_CR11","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1245\/s10434-019-07867-x","volume":"26","author":"TA Moo","year":"2019","unstructured":"Moo TA, Jochelson MS, Zabor EC, et al. Is clinical exam of the axilla sufficient to select node-positive patients who downstage after NAC for SLNB? A comparison of the accuracy of clinical exam versus MRI. Ann Surg Oncol. 2019;26(13):4238\u201343.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"20257_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/SLA.0000000000004356","volume":"273","author":"S Samiei","year":"2021","unstructured":"Samiei S, De Mooij CM, Lobbes MBI, et al. Diagnostic performance of noninvasive imaging for assessment of axillary response after neoadjuvant systemic therapy in clinically node-positive breast cancer: a systematic review and meta-analysis. Ann Surg. 2021;273(4):694\u2013700.","journal-title":"Ann Surg."},{"issue":"15","key":"20257_CR13","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1200\/JCO.2001.19.15.3516","volume":"19","author":"WB Eubank","year":"2001","unstructured":"Eubank WB, Mankoff DA, Takasugi J, et al. 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol. 2001;19(15):3516\u201323.","journal-title":"J Clin Oncol."},{"issue":"6","key":"20257_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1524-4741.2010.00987.x","volume":"16","author":"I Segaert","year":"2010","unstructured":"Segaert I, Mottaghy F, Ceyssens S, et al. Additional value of PET-CT in staging of clinical stage IIB and III breast cancer. Breast J. 2010;16(6):617\u201324.","journal-title":"Breast J."},{"issue":"8","key":"20257_CR15","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.7863\/ultra.34.8.1385","volume":"34","author":"YU An","year":"2015","unstructured":"An YU, Kim SH, Kang BJ, et al. Comparisons of positron emission tomography\/computed tomography and ultrasound imaging for detection of internal mammary lymph node metastases in patients with breast cancer and pathologic correlation by ultrasound-guided biopsy procedures. J Ultrasound Med. 2015;34(8):1385\u201394.","journal-title":"J Ultrasound Med."},{"issue":"1012","key":"20257_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1259\/bjr\/32906819","volume":"85","author":"P Britton","year":"2012","unstructured":"Britton P, Warwick J, Wallis MG, et al. Measuring the accuracy of diagnostic imaging in symptomatic breast patients: team and individual performance. Br J Radiol. 2012;85(1012):415\u201322.","journal-title":"Br J Radiol."},{"issue":"3","key":"20257_CR17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1148\/radiol.2523080670","volume":"252","author":"N Abdullah","year":"2009","unstructured":"Abdullah N, Mesurolle B, El-Khoury M, et al. Breast imaging reporting and data system lexicon for us: interobserver agreement for assessment of breast masses. Radiology. 2009;252(3):665\u201372.","journal-title":"Radiology."},{"issue":"12","key":"20257_CR18","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1007\/s00259-015-3102-x","volume":"42","author":"AM Garc\u00eda Vicente","year":"2015","unstructured":"Garc\u00eda Vicente AM, Soriano Castrej\u00f3n \u00c1, L\u00f3pez-Fidalgo JF, et al. Basal 1\u2078F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography as a prognostic biomarker in patients with locally advanced breast cancer. Eur J Nucl Med Mol Imaging. 2015;42(12):1804\u201313.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"3","key":"20257_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1148\/rg.2021200134","volume":"41","author":"B Reig","year":"2021","unstructured":"Reig B, Lewin AA, Du L, et al. Breast MRI for evaluation of response to neoadjuvant therapy. Radiographics. 2021;41(3):665\u201379.","journal-title":"Radiographics."},{"issue":"10","key":"20257_CR20","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.1007\/s00330-024-10695-7","volume":"34","author":"S Goulam-Houssein","year":"2024","unstructured":"Goulam-Houssein S, Ye XY, Fleming R, et al. Evaluating persistent T1-weighted lesions without concurrent abnormal enhancement on breast MRI in neoadjuvant chemotherapy patients: implications for complete pathological response. Eur Radiol. 2024;34(10):6273\u201382.","journal-title":"Eur Radiol."},{"issue":"6","key":"20257_CR21","doi-asserted-by":"publisher","first-page":"E210891","DOI":"10.1001\/jamasurg.2021.0891","volume":"156","author":"S Samiei","year":"2021","unstructured":"Samiei S, Simons JM, Engelen SME, et al. Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis. JAMA Surg. 2021;156(6):E210891.","journal-title":"JAMA Surg."},{"issue":"2","key":"20257_CR22","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1245\/s10434-023-14541-w","volume":"31","author":"AA Woodfin","year":"2024","unstructured":"Woodfin AA, Yam C, Teshome M, et al. Axillary nodal metastases conversion and perioperative complications with neoadjuvant pembrolizumab therapy in triple-negative breast cancer. Ann Surg Oncol. 2024;31(2):974\u201380.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"20257_CR23","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","volume":"382","author":"P Schmid","year":"2020","unstructured":"Schmid P, Cortes J, Pusztai L, et al. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020;382(9):810\u201321.","journal-title":"N Engl J Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20257-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20257-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20257-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:52:46Z","timestamp":1789667566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20257-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20257"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20257-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}